Li et al.’s (2016)s research found that ZEB1-AS1 promotes tumor growth and metastasis and is significantly associated with tumor recurrence. Zhen-Jiang Ma et al. (2020) found that ZEB1-AS1 can promote bone metastasis in liver cancer through the miR-302b-EGFR-PI3K-AKT axis. Here, AKT1 is linked to liver cancer.